These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6242682)

  • 1. [Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
    Alexander H; Ulrich FE; Herter U
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6242682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carbohydrate metabolism in normo- and hyperprolactinemic sterility patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
    Alexander H; Ulrich FE; Herter U
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6211038
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences with the treatment of clinical hyperprolactinaemia.
    Nagy P; Szilágyi A; Csaba IF
    Zentralbl Gynakol; 1987; 109(12):788-94. PubMed ID: 3630462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic results in hyperprolactinemic sterility patients].
    Melzer H
    Zentralbl Gynakol; 1987; 109(8):517-20. PubMed ID: 3604494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sterility in hyperprolactinemic amenorrhea].
    Tscherne G; Urdl W
    Zentralbl Gynakol; 1983; 105(8):478-81. PubMed ID: 6868876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
    Eftekhari N; Mohammadalizadeh S
    Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
    Polishuk WZ; Yarkoni S; Ben-David M; Spitz J
    Harefuah; 1975 Dec; 89(11):500-3. PubMed ID: 1205386
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia.
    Weingrill CO; Mussio W; Moraes CR; Portes E; Castro RC; Lengyel AM
    Fertil Steril; 1992 Feb; 57(2):331-5. PubMed ID: 1735484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of parlodel for the treatment of endocrine sterility in women with hyperprolactinemic amenorrhea].
    Persianinov LS; Pshenichnikova TIa; Manuilova IA; Sotnikova EI
    Akush Ginekol (Mosk); 1979 May; (5):21-3. PubMed ID: 474897
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the treatment of hyperprolactinemic conditions].
    Nagy P; Szilágyi A; Csaba I
    Orv Hetil; 1986 Mar; 127(10):573-6. PubMed ID: 3703537
    [No Abstract]   [Full Text] [Related]  

  • 13. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinemia and its effect on female sterility.
    Atasü T; Kösebay D; Arvas M
    Biol Res Pregnancy Perinatol; 1985; 6(3):133-6. PubMed ID: 3834948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience in treating women with pathologic functional hyperprolactinemia and normal blood prolactin levels with bromocriptine].
    Markovski N; Ivanov S; Trepechev S; Spasiov S; Zhekova V
    Akush Ginekol (Sofiia); 1983; 22(6):417-22. PubMed ID: 6673607
    [No Abstract]   [Full Text] [Related]  

  • 16. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of parlodel treatment in women with hyperprolactinemia].
    Pakhomova IA; Manuilova IA; Afonina LI; Nazarenko TA
    Akush Ginekol (Mosk); 1984 May; (5):8-11. PubMed ID: 6465465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience obtained from prolactin-inhibiting therapy for functional sterility (author's transl)].
    Gazárek F; Zenisek L; Talas M; Stehliková J; Fingerová H
    Zentralbl Gynakol; 1980; 102(20):1145-7. PubMed ID: 7211013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I
    Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.